Treatment Routes for Exploring Agitation (TREA)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine the efficacy of non-pharmacological ways to treat agitated behaviors in nursing home residents with dementia. The hypothesis is that non-pharmacological interventions will be more effective than placebo in decreasing such behaviors.
| Condition | Intervention |
|---|---|
|
Dementia Behavior Problems |
Behavioral: TREA (Treatment Routes for Exploring Agitation) Behavioral: Placebo Control Group |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Treatment of Agitation in the Nursing Home |
- Agitation Behavior Mapping Instrument (ABMI) [ Time Frame: 10 days of intervention vs. 10 days of baseline ] [ Designated as safety issue: No ]
- affect/mood measured by Lawton's behavior stream assessment [ Time Frame: 10 days of intervention vs. 10 days of baseline ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | June 2006 |
| Estimated Study Completion Date: | June 2011 |
| Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 |
Behavioral: TREA (Treatment Routes for Exploring Agitation)
Individualized non-pharmacological treatment plan for agitation
|
| Active Comparator: 2 |
Behavioral: Placebo Control Group
A presentation on the treatment of behavior problems in dementia given to the staff caregivers of the comparison group
|
Detailed Description:
Clinicians often refer to elderly persons under their care as "agitated." However, agitation is not a diagnosis, but rather, a descriptive term pertaining to a group of behavioral signs and symptoms, defined as socially inappropriate verbal, vocal, or motor (physical) activity that is not judged by an outside observer to result directly from the needs or confusion of the agitated individual. While the literature reports positive effects of non-pharmacological interventions, most studies tend to be based on small samples and do not yield statistically significant results. This study examines the impact of non-pharmacologic interventions tailored through an algorithm labeled TREA (Treatment Routes for Exploring Agitation) using a large, well-controlled, systematic research design.
TREA is an objective, systematic method for developing individualized non-pharmacological treatment plans based on an analysis of the agitated person's unmet needs, past and current preferences, past role-identity, cognitive, mobility, and sensory abilities/limitations, and possible causes for particular agitated behaviors. The methodology calls for ascertaining the type of agitated behavior and the most likely etiology, and then matching the intervention to the etiology and to the participant's characteristics.
The protocol involves the following steps:
- Baseline assessment - using standardized assessments (e.g., MMSE, ABMI, CMAI, Self-identity in dementia), collecting background demographic and medical information as well as systematic observations of the agitated resident
- Intervention exploration - after analyzing potential unmet needs as well as preferences, abilities and identities of each participant, investigators develop a list of potentially successful interventions, examining the effectiveness of a wide range of interventions, from family videos to manipulatives (e.g., puzzles, a tool kit)
- Intervention (treatment) phase — Interventions are systematically provided during the hours of highest agitation (determined at baseline) and observations are conducted at the same time. The treatment phase lasts for 10 days. The placebo control group includes a presentation to staff members as to how to intervene with behavior problems and similar observations of residents.
- Follow-up phase includes repeated assessments without interventions.
Eligibility| Ages Eligible for Study: | 60 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 60 or older
- Diagnosis of dementia derived from the resident's medical chart at the facility or from an attending physician, as based on DSM-IV criteria and the Report of the NINCDS-ADRDA
- Resident of the facility for at least three weeks so that nursing staff members know the resident well enough to accurately assess him or her
- Identified by nursing staff to exhibit either verbal agitation or physical non-aggressive agitation at least several times a day
Exclusion Criteria:
- Lifelong diagnosis of schizophrenia
- Bipolar disorder diagnosed prior to onset of dementia
- Diagnosis of premorbid mental retardation
- Judged by direct-care nursing staff to have a life expectancy of less than 3 months
- Expected to leave the nursing home (either to enter the hospital or to go home) within the next 4 months
- Agitation manifested less than 6 times a day
Contacts and Locations| Contact: Jiska Cohen-Mansfield, PhD | 301-770-8453 | cohen-mansfield@hebrew-home.org |
| Contact: Marcia S. Marx, PhD | 301-770-8451 | marx@hebrew-home.org |
| United States, Maryland | |
| Research Institute on Aging | Recruiting |
| Rockville, Maryland, United States, 20814 | |
| Contact: Jiska Cohen-Mansfield, PhD, ABPP 301-770-8453 cohen-mansfield@hebrew-home.org | |
| Contact: Marcia Marx, PhD 301-770-8451 marx@hebrew-home.org | |
| Principal Investigator: Jiska Cohen-Mansfield, PhD, ABPP | |
| Sub-Investigator: Marcia Marx, PhD | |
| Principal Investigator: | Jiska Cohen-Mansfield, PhD | Research Institute on Aging |
More Information
Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Jiska Cohen-Mansfield, Ph.D., Director, Research Institute on Aging |
| ClinicalTrials.gov Identifier: | NCT00820859 History of Changes |
| Other Study ID Numbers: | IA0144, 5 R01 AG10172-11 |
| Study First Received: | January 8, 2009 |
| Last Updated: | July 1, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute on Aging (NIA):
|
Cognition disorder nursing home residents agitation behavior disorder |
Additional relevant MeSH terms:
|
Dementia Psychomotor Agitation Brain Diseases Central Nervous System Diseases Nervous System Diseases Delirium, Dementia, Amnestic, Cognitive Disorders |
Mental Disorders Dyskinesias Neurologic Manifestations Psychomotor Disorders Neurobehavioral Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on June 18, 2013